0001213900-20-029372.txt : 20200930
0001213900-20-029372.hdr.sgml : 20200930
20200930210018
ACCESSION NUMBER: 0001213900-20-029372
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200929
FILED AS OF DATE: 20200930
DATE AS OF CHANGE: 20200930
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McWilliams David
CENTRAL INDEX KEY: 0001303311
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39555
FILM NUMBER: 201214020
MAIL ADDRESS:
STREET 1: 2575 WEST BELLFORT STREET
CITY: HOUSTON
STATE: TX
ZIP: 77054-9816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Greenwich LifeSciences, Inc.
CENTRAL INDEX KEY: 0001799788
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205473709
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3992 BLUEBONNET DR, BUILDING 14
CITY: STAFFORD
STATE: TX
ZIP: 77477
BUSINESS PHONE: 203-434-3290
MAIL ADDRESS:
STREET 1: 3992 BLUEBONNET DR, BUILDING 14
CITY: STAFFORD
STATE: TX
ZIP: 77477
4
1
ownership.xml
X0306
4
2020-09-29
0
0001799788
Greenwich LifeSciences, Inc.
GLSI
0001303311
McWilliams David
C/O GREENWICH LIFESCIENCES, INC.
3992 BLUEBONNET DR., BUILDING 14
STAFFORD
TX
77477
1
0
0
0
Common Stock
2020-09-29
4
M
0
152604
A
599583
D
Common Stock
2020-09-29
4
M
0
7663
A
607246
D
Common Stock
2020-09-29
4
M
0
3746
A
610992
D
Common Stock
2020-09-29
4
M
0
7609
A
618601
D
Series A Preferred Stock
2020-09-29
4
M
0
152604
0
D
Common Stock
152604
0
D
Series B Preferred Stock
2020-09-29
4
M
0
7663
0
D
Common Stock
7663
0
D
Series C Preferred Stock
2020-09-29
4
M
0
3746
0
D
Common Stock
3746
0
D
Series D Preferred Stock
2020-09-29
4
M
0
6555
0
D
Common Stock
6555
0
D
Series D Preferred Stock
2020-09-29
4
J
0
1054
0
A
Common Stock
1054
1054
D
Series D Preferred Stock
2020-09-29
4
M
0
1054
0
D
Common Stock
1054
0
D
The Series A Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
The Series B Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
The Series C Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
The Series D Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
The Series D Preferred Stock have no expiration date and are convertible, at the option of the holder, into shares of common stock of the Issuer at the then-effective conversion rate for no additional consideration (subject to the payment of cash, if applicable, in lieu of any fractional shares in accordance with the Issuer's Amended and Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation").
The Reporting Person was issued additional shares of Series D Preferred Stock in connection with the Issuer's initial public offering as a result of the anti-dilution protection provisions set forth in the Issuer's Certificate of Incorporation.
/s/ David McWilliams
2020-09-30